Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
GI Innovation, Inc.
Compass Therapeutics
Mayo Clinic
Mayo Clinic
Hoffmann-La Roche
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Bristol-Myers Squibb
AstraZeneca
Pfizer
Duke University
Tizona Therapeutics, Inc
Genentech, Inc.
A2 Biotherapeutics Inc.
Poseida Therapeutics, Inc.
MacroGenics
National Institutes of Health Clinical Center (CC)
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Novartis
Elephas
City of Hope Medical Center
Mayo Clinic
GlaxoSmithKline
Sairopa B.V.
City of Hope Medical Center
EMD Serono
NeoTX Therapeutics Ltd.
Medtronic - MITG
HiFiBiO Therapeutics
Bolt Biotherapeutics, Inc.
University of Pittsburgh
Incyte Corporation
Actym Therapeutics, Inc.
MacroGenics
Chongqing Precision Biotech Co., Ltd
Pfizer
Travera Inc
Pfizer
Incyte Corporation
Guardant Health, Inc.
Exelixis
Incyte Corporation
Jonsson Comprehensive Cancer Center
Xencor, Inc.
Toray Industries, Inc